DeepLook Medical Announces First Close of Series A and Releases
Metropolitan New York Hospital Achieves 12% Improvement in Performance with DL Precise™ [New Haven, Connecticut, September 18, 2024] —...
DeepLook Medical Announces First Close of Series A and Releases
DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates
DeepLook Medical Secures 2nd Patent
UK Regulatory Approval for DL Precise™ Software
Women's Health Makes 1st Appearance on Agenda of Mobile World Congress
DeepLook Medical Secures $1.7 Million to Revolutionize Cancer Detection in Dense Breasts
DeepLook Highlighted by FemTech World
Forbes Features DL Precise™